PUBLISHER: Grand View Research | PRODUCT CODE: 1985889
PUBLISHER: Grand View Research | PRODUCT CODE: 1985889
The global medical device contract development and manufacturing organization market size was valued at USD 134.65 billion in 2025 and is projected to reach USD 354.60 billion by 2033, growing at a CAGR of 13.12% from 2026 to 2033. The market growth is mainly driven by shifting trends towards outsourcing, the increasing need for specialized expertise, rising demand for advanced products, and the growing shift towards home care and minimally invasive treatments.
The medical device contract development and manufacturing organization (CDMO) market is expanding rapidly as OEMs in large numbers outsource development and manufacturing to address regulatory complexity, high capital costs, and the need for specialized engineering expertise. Besides this, partnering with CDMOs allows OEMs to focus on R&D and commercialization while leveraging scalable production, process validation, and global regulatory support. This trend is particularly strong for minimally invasive, implantable, and connected devices requiring advanced manufacturing and strict compliance. In addition, outsourcing also reduces time-to-market through automation, additive manufacturing, and smart quality systems. In addition, it improves cost efficiency and risk mitigation by utilizing ISO-certified facilities. For instance, in January 2026, Jabil agreed to partner with TxSphere, highlighting the growing reliance on CDMOs for complex drug-device combination products.
In addition, rising demand for advanced medical devices is driving growth in the global medical device CDMO market, as OEMs outsource complex, technology-intensive development and manufacturing. Chronic disease prevalence, aging populations, and adoption of connected diagnostics, AI-enabled systems, and wearable devices are fueling market growth. Besides this, CDMOs provide precision manufacturing, electronics integration, and regulatory expertise, supported by investments in additive manufacturing and automation. In addition, expanding digital health frameworks and streamlined regulatory pathways further accelerate commercialization.
Furthermore, the growing need for highly specialized expertise is a major driver of the medical device contract development and manufacturing organization industry, as rapid innovation and increasing product complexity exceed the in-house capabilities of many manufacturers. Additionally, modern medical devices combine advanced materials, embedded software, miniaturized components, and stringent regulatory requirements, requiring multidisciplinary expertise. In addition, many small and mid-sized OEMs lack the resources to efficiently design, validate, and scale such complex products. Thus, by partnering with CDMOs offering specialized capabilities in design optimization, prototyping, advanced manufacturing, and regulatory compliance, companies can accelerate time-to-market and reduce development risks.
Moreover, the shift toward home care solutions and minimally invasive treatments is accelerating growth in the medical device CDMO industry. Healthcare systems are prioritizing cost reduction, patient comfort, and faster recovery, driving demand for wearable monitors, point-of-care diagnostics, and minimally invasive surgical tools. These devices require advanced materials, embedded software, precision engineering, and strict regulatory compliance capabilities, often outsourced to specialized CDMOs. In addition, home-use products require rigorous usability testing and safety validation. Many OEMs, particularly startups, rely on CDMOs for comprehensive support, from design and prototyping to large-scale manufacturing, sterilization, packaging, and regulatory navigation, strengthening CDMOs' strategic role.
Global Medical Device Contract Development And Manufacturing Organization Market Report Segmentation
This report forecasts revenue growth at the global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2021 to 2033. For this study, Grand View Research has segmented the global medical device contract development and manufacturing organization market report based on product, service, class, application, end use, and region: